Learn more

LIBRAGEN

Overview
  • Total Patents
    49
  • GoodIP Patent Rank
    223,169
  • Filing trend
    ⇩ 100.0%
About

LIBRAGEN has a total of 49 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets organic fine chemistry, biotechnology and pharmaceuticals are COMBINATURE BIOPHARM AG, JIANG YANG and ERREKAPPA EUROTERAPICI SAS.

Patent filings per year

Chart showing LIBRAGENs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Nalin Renaud 46
#2 Lefevre Fabrice 28
#3 Auriol Daniel 24
#4 Robe Patrick 21
#5 Tuphile Karine 11
#6 Gillet Benjamin 11
#7 Ginolhac Aurelien 7
#8 Pujic Petar 6
#9 Bensoussan Claude 5
#10 Monsan Pierre 5

Latest patents

Publication Filing date Title
GB201700440D0 Method
FR2958157A1 Cosmetic and pharmaceutical composition comprising n-acetyl-glucosamine-6-phosphate
EP2202237A1 Hydrosoluble [6)-O-alpha-d-glcp-(1->]n-6-o-bêta-d-glcp-(1->-phenllic derivatives with dermocosmetic, nutritional and therapeutic applications, and compositions containing said water soluble compounds
EP1995323A1 Method for preparing C-6 phosphorylated D-aldohexoses and C-6 phosphorylated D-aldohexose derivatives
EP1867729A1 Water soluble phenolics derivatives with dermocosmetic and therapeutic applications
EP1842915A1 Method of in vitro polynucleotide sequences shuffling by recursive circular DNA molecules fragmentation and ligation
WO2005095634A1 Method for the identification of a metabolic pathway family by means of positive selection
EP1386966A1 Method for the expression of unknown environmental DNA into adapted host cells
EP1277835A1 Methods of creating genetic diversity
CA2407270A1 Method for indirectly extracting non-cultivable dna organisms and dna obtainable by said method